# Embecta to acquire Owen Mumford Holdings for up to £150M

Embecta Corp. entered a definitive agreement to acquire Owen Mumford Holdings Limited, a UK-based medical device and drug-delivery technology company, for up to £150 million (£100 million upfront plus up to £50 million in performance-based payments). The transaction is expected to close in Embecta's fiscal third quarter of 2026.

- Type: Acquisition
- Announced: 2026-03-19
- Where: United Kingdom
- Value: $190.0M (150.0M GBP)
- Status: announced
- Products: drug delivery devices, autoinjectors, point-of-care testing devices, pelvic health devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Owen Mumford](https://endata.com/companies/59279.md) (target)
- [Embecta Corp.](https://endata.com/companies/90942.md) (acquirer)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2026/03/19/3258815/0/en/embecta-announces-definitive-agreement-to-acquire-owen-mumford-holdings-limited.html), 2026-03-19: "Embecta Corp. today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited, a privately held, UK‑based innovator and manufacturer of medical devices and drug‑delivery technologies, in a transaction valued at up to £150 million."
- [finance.yahoo.com](https://finance.yahoo.com/sectors/healthcare/articles/embecta-announces-definitive-agreement-acquire-103000495.html), 2026-03-19: "Embecta Corp. today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited, a privately held, UK‑based innovator and manufacturer of medical devices and drug‑delivery technologies, in a transaction valued at up to £150 million."
- [barchart.com](https://www.barchart.com/press-releases/865754/embecta-announces-definitive-agreement-to-acquire-owen-mumford-holdings-limited), 2026-03-19: "Embecta Corp. today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited, a privately held, UK‑based innovator and manufacturer of medical devices and drug‑delivery technologies, in a transaction valued at up to £150 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.